Back

LOXL-2 as a marker of myocardial fibrosis, remodeling, and outcomes in severe rheumatic mitral regurgitation

12 May 2026 (08:30 - 09:15)
Organised by: Logo
Congress Presentation Part of: Mitral valve disease: mechanisms and management Mitral Valve Regurgitation Delegates Premium Access Heart Failure 2026 Heart Failure Association (HFA)

About the speaker

Photo
Mrs Santoshi Kumari Sahani

All India Institute of Medical Sciences AIIMS New Delhi, New Delhi (India)

5 More presentations in this session

Presentation thumbnail
Mitral regurgitation as an inflammatory valvular phenotype in heart failure
Doctor V. Copeland (Ramat Gan, IL)
Abstract Slides
Presentation thumbnail
Development of a risk score for acute kidney injury in infective endocarditis
Doctor J. Gouveia Fiuza (Viseu, PT)
Abstract Slides
Presentation thumbnail
Ventricular-valvular-vascular coupling in patients with severe aortic stenosis: changes after surgery and prognostic significance
Doctor D. Da Silva Correia (Lisbon, PT)
Abstract Slides
Presentation thumbnail
Determinants and prognostic impact of residual mitral regurgitation after transcatheter edge-to-edge repair
Doctor C. Santos Jorge (Lisbon, PT)
Abstract Slides
Presentation thumbnail
Prognostic impacts of post-procedural right ventricular fractional area change in patients after mitral valve transcatheter edge-to-edge repair
Doctor M. Maeda (Kumamoto, JP)
Abstract Slides

Access the full session

Session thumbnail
Mitral valve disease: mechanisms and management

The Event

Event poster

Heart Failure 2026

12 May 2026 08:30 CET

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources